MENU
ADCT
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

ADC Therapeutics SA (ADCT) Ownership - Who owns ADC Therapeutics SA?

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company... Show more

Profile

Industry
N/A
Address
Route de la Corniche 3B
Phone
+41 216530200
Employees
274
Web
https://www.adctherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
459.58M
P/E Ratio
N/A
Total Cash
234.74M
Projected Growth
N/A
Total Debt
117.27M
Revenue
75.21M
Risk (Beta)
3.41
Dividend Yield
N/A
Total Cash/Share
1.89
Total Debt/Equity
N/A
Revenue/Share
0.65 USD as % of share price

Fundamentals

ADCT
Capitalization
460M
P/E Ratio
N/A
Risk (Beta)
3.41
Dividend Yield
N/A
Total Cash
235M
Total Cash/Share
1.89
Total Debt
117M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.65%
Revenue
75.2M
ROE
N/A
Book Value
-238.18M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-1.41
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
9.76M
Current Ratio
4.63
Current Revenue Per Employee
62460.07
Dividends Per Share - Security
N/A
EBITDA
-112.75M
Float
N/A
Float - Current
N/A
Gross Income Margin
92.68
Revenue To Assets
-52.26
Shares Held By Institutions
407M
Shares Outstanding - Current
124M
Total Liabilities
528M
Total Volume MTD
N/A
Value
1
Gain YTD
5.099
View a ticker or compare two or three
ADCT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ADCT showed earnings on November 10, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Route de la Corniche 3B
Phone
+41 216530200
Employees
274
Web
https://www.adctherapeutics.com